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Comparative physico-chemical nd spectroscopic analyses were carried out in human lens proteins obtained from extracts of normal, senile and 
PUVA cataracts. Mass recovery analysis reveals a large protein concentration loss in the PUVA cataract relative to the normal lens and senile 
cataract. This protein loss parallels an increase in the degraded polypeptide chains. However, the tryptophan content (2.1 mol/mol of 20 kDa protein 
subunit) and the apparent fluorescence quantum yield (cpr=O.O56) of the tryptophan residues which are believed to be involved in the development 
of UV-induced cataracts are unchanged after age-related alterations and/or in vivo photochemistry associated with psoralen @MOP) photosensi- 
tized reactions. 
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1. INTRODUCTION 
The conjugated effect of UV and aging leads to the 
oxidation of human lens proteins which become yellow, 
fluorescent and undergo polymerization [ 1,2]. The 
study of the modifications induced by endogenous 
[3-51 or exogenous photosensitizers uch as drugs has 
been stimulated by the discovery that 8MOP 
photoproducts can be found in cataracts developed by 
patients undergoing PUVA therapy with this psoralen 
derivative [6,7]. It is presently believed that tryp- 
tophan, the only UVB-absorbing amino acid residue in 
proteins is responsible for the primary photochemical 
processes leading to the formation of fluorescent 
pigments and N-formylkynurenine, a photooxidation 
product of Trp which is a good photosensitizer [2,4]. 
However, it has been shown that although Trp in vitro 
is very sensitive to UV photolysis in model systems, Trp 
residues are rather stable to photooxidation in human 
lens aging processes leading to cataract formation [8,9]. 
This surprisingly different behavior has been called the 
lens paradox [lo]. 
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The present work deals with the physicochemical and 
spectroscopic modifications of the ocular lens during 
the normal lens aging (senile cataract formation) and 
during the cataractogenesis nduced in the lens of a 
psoriatic patient undergoing PUVA therapy with 
8MOP. Using physicochemical, biochemical and spec- 
troscopic techniques, the molecular size, the variation 
of the concentration, the content in Trp residues and 
the fluorescence quantum yield of human LY, ,&, pr, 
LM and y-crystallins from a normal completely 
transparent lens, from a senile cataract and from a 
PUVA-induced cataract have been determined. 
2. EXPERIMENTAL 
2.1. Crystailins 
Fresh crystallins weighing about 175 mg (expressed in fresh tissues) 
were obtained from human donors, 28 years old (normal lens), 6.5 
years old (senile cataract) and 57 years old (PUVA cataract) at the 
Departamento de Oftalmologia e de Dermatologia do Hospital de 
Santa Maria, Lisboa. Crystallins were solubilized after homogeniza- 
tion (nucleus and cortex) in a pH 7.5 Tris buffer containing 50 mM 
NaCl. The solutions were extensively dialyzed at 4°C to remove salts 
and then lyophilized and stored at -20°C until used. 
The clinical aspects regarding the psoriatic patient are described 
elsewhere [111. 
2.2. Low pressure get permeation liquid chromatography (FPLC) 
The various protein fractions of the crystallins were separated ac- 
cording to their molecular weight with a Pharmacia FPLC equipment 
using Superose 6 or 12 columns provided by Pharmacia Fine 
Chemicals. The eluent was the solution used fcr the homogenization. 
Superose columns were calibrated with proteins of known 
molecular mass purchased from Sigma. The following standards were 
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used: thyroglobulin (670 kDa), ,&amylase (200 kDa), alcohol 
dehydrogenase (150 kDa), bovine serum albumin (68 kDa), carbonic 
anhydrase (31 kDa) and cytochrome c (12.5 kDa). For each 
chromatogram, 300 ~1 of a buffered solution containing 6 mg/ml of 
lyophilized crystallins were injected and 40041 fractions were col- 
lected. The protein concentration in each pooled fraction of the five 
crystallin proteins was determined by the Lowry method 1121. 
2.3. Spectroscopic analysis 
Absorption spectra were recorded with a Perkin-Elmer Lambda 9 
spectrophotometer whereas the fluorescence was studied with a 
SPEX Fluorolog fluorometer. 
2.4. Alkaline denaturation 
The Trp content of the five crystallin fractions was determined 
after alkaline denaturation with 2 M KOH by measuring the Trp 
fluorescence at 350 nm according to the method described in [13]. 
3. RESULTS AND DISCUSSION 
3.1. Biochemical and physicochemical analysis 
The separation by FPLC of a constant mass of 
lyophilized proteins extracted from a normal lens, from 
a senile and from a PUVA cataract is shown in Fig. 1. 
The molecular masses found for the cy, &, ,&, LM and 
y-proteins are 800, 150, 90, 45 and 20 kDa, respective- 
ly. They are in good agreement with previously 
reported values [14]. Furthermore, they are identical 
for the three studied lenses. 
The most important differences between the three 
chromatograms reside in their absorbance at 280 nm 
and the presence of low molecular weight peptides 
(Fig. 1). The decrease in the absorbance of the protein 
fractions of the PUVA cataract at 280 nm with respect 
to the same fractions obtained with the normal or senile 
lens may suggest either the photodegradation of the in- 
dole ring or a protein concentration loss. 
The determination of the protein concentration by 
the Lowry method on the chromatographed fractions 
leads to a protein mass from the PUVA cataract which 
represents only a quarter of the mass obtained with the 
normal and senile lenses (Table I). Moreover, a larger 
proportion of proteins eluting at the same time as the 
a-crystallin is found in the cataractous lens as com- 
pared to the normal lens. These heavy fractions amount 
to about 23, 47 and 74% in the normal, senile and 
PUVA crystallins, respectively. 
Despite the experimental error (about 20%) inherent 
in the determination of the protein concentration by the 
Lowry method, the protein loss observed with the 
PUVA cataract is highly significant. This loss is par- 
ticularly important for the low molecular weight frac- 
tions (Table I). The PUVA lens chromatogram (Fig. 1) 
shows that the protein loss parallels the appearance of 
fractions with a molecular mass lower than 10 kDa 
which probably correspond to degraded polypeptidic 
chains [15]. The relatively small amounts that are ob- 
tained with chromatography preclude their analysis. It 
should be emphasized that shorter peptides may not 
Retention time (mln) 
Fig. 1. FPLC chromatogram on Superose 12 of the various protein 
fractions of the three human lenses. Absorbance was measured at 
280 nm as a function of the retention time (min). The rectangle on 
the bottom chromatogram emphasizes the increased production of 
small peptides (see text). 
have been detected under the present experimental con- 
ditions. 
The Trp content of the CY, ,&, PL, LM and y- 
crystallins of the three lenses, measured after alkaline 
denaturation, is constant and equal to 2.1 mol/mol of 
Trp per 20 kDa subunit. These values are also in good 
agreement with the literature [16]. 
The linear relationship between the absorbance at 
280 nm and the protein content of the a-, &, y-proteins 
of the three lenses (data not shown) suggests that they 
Table I 
Determination of the protein concentration in the various crystallin 
fractions by the Lowry method 
Fraction 
cr 
IBH 
PL 
LM 
Got al 
Normal lens Senile cataract PUVA cataract 
69 141 52 
10 20 5 
48 38 3 
83 64 4.5 
260 5 339 76 2.9 
67.4 
Results are expressed as peg of fraction/mg of lyophilized crystallin 
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all have the same specific absorbance, i.e. E$rL,, = 30. 
Moreover, the comparison of the specific absorbance 
of the individual proteins demonstrates that the 
cataractogenesis does not change this specific absor- 
bance. It has to be mentioned that the theoretical 
specific absorbance at 280 nm due to 2 Trp residues 
and 5 or 6 Tyr residues [16] is always smaller than the 
experimental value [17]. In the present study it cor- 
responds to 30% of the observed specific absorbance. 
The presence of other chromophores could explain, at 
least in part, the additional absorbance. 
3.2. Emission spectroscopy 
In agreement with the constant value of the number 
of Trp residues in the studied crystallins, the 
fluorescence maximum wavelength and the 
fluorescence quantum yield (& = 0.056 & 0.01) are not 
modified in the various protein fractions of the three 
lenses. In fact, this is consistent with the conservation 
of the secondary structure of the proteins of the human 
lenses during the cataractogenesis [ 181. 
In addition, the increased exposure of Trp residues to 
a hydrophilic environment in going from y- to CY- 
crystallins, which corresponds to a 12 nm red-shift of 
the fluorescence maximum, should lead to enhanced 
photochemical susceptibility of these residues in the 
high molecular weight proteins [18]. However, the 
more important degradation of low molecular weight 
proteins in the PUVA cataract, may suggest hat indole 
rings are not involved in the cataractogenesis nduced 
by 8MOP. 
Phosphorescence and fluorescence spectroscopies do 
not make it possible to detect the presence of SMOP 
photoproducts in the various protein fractions of the 
PUVA lens. Thus, excitation at 330 nm leads to the 
typical fluorescence of the eye pigments with bands 
centered at 420 and 465 nm. It corresponds to the so- 
called NT (non-tryptophan) fluorescence [19]. At low 
temperature, a phosphorescence emission is observed at 
450 nm which has been attributed to 8MOP 
photoproducts by Lerman [6]. However, this 
phosphorescence is present in all the fractions whatever 
the observed lens. 
4. CONCLUSIONS 
In a normal cataractogenic process induced by aging 
of the eye lens (senile cataract), the photooxidation of 
proteins leads to an increased aggregation of LY- 
crystallins. As a consequence, the solubility of the pro- 
teins decreases. The present results show that the 
presence of a photosensitizer such as 8MOP (PUVA 
cataract) tends to aggravate this process characterized 
by the relative increase in the percentage of cy- 
crystallins. On the other hand, it can be seen that the 
PUVA lens was more easily solubilized than the senile 
proteins. Furthermore the relative increase in the heavy 
74 
fractions observed with the PUVA cataract is accom- 
panied by an increased formation of small peptides 
which are not found in the senile cataract. These results 
suggest hat the primary chemical mechanisms of the 
cataractogenic damage in the senile and PUVA 
cataracts are not the same. 
As far as the protein fragmentation is concerned, one 
may suggest wo possible mechanisms. The first one 
could involve a post-oxidative proteolytic activity as 
already proposed for the radical-induced degradation 
of mitochondrial proteins [20]. The second possibility 
is the occurrence of secondary chemical reactions due 
to the propagation of damage induced at primary 
photochemical targets. 
Despite the large mass variations observed with the 
various proteins of the PUVA lens, the biochemical 
and spectroscopic analyses do not demonstrate any 
modification in the number of their Trp residues as 
compared to similar fractions of the senile and normal 
lenses. 
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